Oxford Nanopore Technologies (ONT) Competitors GBX 149.30 -3.10 (-2.03%) As of 11:54 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock ONT vs. BTG, ABC, GNS, ERGO, OXB, SLN, PRTC, HZD, AVCT, and VRPShould you be buying Oxford Nanopore Technologies stock or one of its competitors? The main competitors of Oxford Nanopore Technologies include BTG (BTG), Abcam (ABC), Genus (GNS), Ergomed (ERGO), Oxford Biomedica (OXB), Silence Therapeutics (SLN), PureTech Health (PRTC), Horizon Discovery Group plc (HZD.L) (HZD), Avacta Group (AVCT), and Verona Pharma plc (VRP.L) (VRP). These companies are all part of the "biotechnology" industry. Oxford Nanopore Technologies vs. Its Competitors BTG Abcam Genus Ergomed Oxford Biomedica Silence Therapeutics PureTech Health Horizon Discovery Group plc (HZD.L) Avacta Group Verona Pharma plc (VRP.L) BTG (LON:BTG) and Oxford Nanopore Technologies (LON:ONT) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends. Is BTG or ONT more profitable? BTG has a net margin of 0.00% compared to Oxford Nanopore Technologies' net margin of -94.82%. BTG's return on equity of 0.00% beat Oxford Nanopore Technologies' return on equity.Company Net Margins Return on Equity Return on Assets BTGN/A N/A N/A Oxford Nanopore Technologies -94.82%-26.02%-14.42% Do insiders and institutionals have more ownership in BTG or ONT? 18.1% of Oxford Nanopore Technologies shares are held by institutional investors. 2.5% of Oxford Nanopore Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Do analysts recommend BTG or ONT? Oxford Nanopore Technologies has a consensus price target of GBX 245, suggesting a potential upside of 64.10%. Given Oxford Nanopore Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Oxford Nanopore Technologies is more favorable than BTG.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BTG 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Oxford Nanopore Technologies 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better earnings and valuation, BTG or ONT? BTG has higher revenue and earnings than Oxford Nanopore Technologies. Oxford Nanopore Technologies is trading at a lower price-to-earnings ratio than BTG, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBTG£914.10M0.00N/A£28.50N/AOxford Nanopore Technologies£204.69M7.03-£175.21M-£0.15-1,008.78 Does the media favor BTG or ONT? In the previous week, BTG had 10 more articles in the media than Oxford Nanopore Technologies. MarketBeat recorded 10 mentions for BTG and 0 mentions for Oxford Nanopore Technologies. Oxford Nanopore Technologies' average media sentiment score of 0.00 beat BTG's score of -0.01 indicating that Oxford Nanopore Technologies is being referred to more favorably in the news media. Company Overall Sentiment BTG Neutral Oxford Nanopore Technologies Neutral SummaryBTG beats Oxford Nanopore Technologies on 7 of the 13 factors compared between the two stocks. Get Oxford Nanopore Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ONT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ONT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ONT vs. The Competition Export to ExcelMetricOxford Nanopore TechnologiesBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£1.44B£231.95M£6.10B£2.61BDividend YieldN/A3.80%5.70%5.28%P/E Ratio-1,008.7894.8985.554,442.02Price / Sales7.036,125.17621.78100,236.46Price / Cash4.0413.1937.7827.90Price / Book2.22116.7513.139.02Net Income-£175.21M-£90.99M£3.30B£5.89B7 Day Performance-5.03%4.47%5.29%0.49%1 Month Performance-12.22%7.21%9.94%5.62%1 Year Performance-1.12%742.62%87.78%164.56% Oxford Nanopore Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ONTOxford Nanopore Technologies2.4768 of 5 starsGBX 149.30-2.0%GBX 245+64.1%+1.9%£1.44B£204.69M-1,008.781,281News CoverageGap UpBTGBTGN/AN/AN/AN/A£3.26B£914.10M29.474,690ABCAbcamN/AN/AN/AN/A£2.81B£350.40M20,433.331,650Gap UpHigh Trading VolumeGNSGenus2.0153 of 5 starsGBX 2,370.19+1.3%GBX 2,900+22.4%+20.5%£1.56B£672.80M-38,228.87480Gap DownERGOErgomedN/AN/AN/AN/A£701.00M£152.09M4,641.386OXBOxford Biomedica1.4777 of 5 starsGBX 558flatGBX 593.67+6.4%+63.9%£670.61M£151.21M-1,336.53891News CoverageAnalyst ForecastSLNSilence TherapeuticsN/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading VolumePRTCPureTech Health1.7877 of 5 starsGBX 133+2.6%GBX 455+242.1%-9.3%£321.44M£6.17M782.35300Positive NewsHZDHorizon Discovery Group plc (HZD.L)N/AN/AN/AN/A£302.98M£54.63M-33.55416AVCTAvacta Group2.535 of 5 starsGBX 58.85+15.4%GBX 99+68.2%+47.3%£236.44M£113K-383.64120VRPVerona Pharma plc (VRP.L)N/AN/AN/AN/A£228MN/A-1.6822Gap Up Related Companies and Tools Related Companies BTG Alternatives Abcam Alternatives Genus Alternatives Ergomed Alternatives Oxford Biomedica Alternatives Silence Therapeutics Alternatives PureTech Health Alternatives Horizon Discovery Group plc (HZD.L) Alternatives Avacta Group Alternatives Verona Pharma plc (VRP.L) Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:ONT) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallySecond Chances Don't Come Often in Crypto My "Crypto Bull Run Millionaire Blueprint" reveals everything - w...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford Nanopore Technologies plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford Nanopore Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
